NCT04260152

Brief Summary

This double blind, randomized, split mouth study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for the treatment of Miller Class I or II recession defects at 6 months post treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 18, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 7, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2020

Completed
Last Updated

August 10, 2021

Status Verified

March 1, 2020

Enrollment Period

1.3 years

First QC Date

September 18, 2019

Last Update Submit

August 9, 2021

Conditions

Keywords

Gingival RecessionFibro-GideCAFCTGGeistlich

Outcome Measures

Primary Outcomes (1)

  • Change in percent root coverage

    Change in percent root coverage compared to baseline

    6 months post-treatment

Secondary Outcomes (10)

  • Safety Endpoints: number and frequency of (S)AEs over all and by organ class

    1, 2, 4, 7, 12 and 24 weeks and year 1,3 and 5 post treatment

  • General Periodontal Examination (GPE)

    baseline (day 0) and 6 months; 1, 3, 5 years post-treatment

  • Assessment of Wound Healing

    1, 2, 4, 12 weeks post-treatment

  • Assessment of Wound Healing

    1, 2, 4, 12 weeks post-treatment

  • Assessment of Wound Healing

    1, 2, 4, 12 weeks post-treatment

  • +5 more secondary outcomes

Study Arms (2)

Control: CAF + CTG

ACTIVE COMPARATOR

Following root preparation and conditioning, the CTG is obtained from the palate according to the randomization scheme and shaped to the recipient site and may be sutured to the papilla region and the coronally advanced flap (CAF) is sutured into place.

Procedure: Connective Tissue Graft (CTG

Test: CAF + Geistlich Fibro-Gide® (test)

EXPERIMENTAL

Following root preparation and conditioning, Geistlich Fibro-Gide® is cut to size and shaped to the recipient and may be sutured and the coronally advanced flap (CAF) is sutured into place.

Device: Geistlich Fibro-Gide

Interventions

Surgical recession root coverage with coronally advanced flap in combination with Geistlich Fibro-Gide

Also known as: Coronally advanced Flap (surgery/ procedure)
Test: CAF + Geistlich Fibro-Gide® (test)

Surgical recession root coverage with coronally advanced flap in combination with CTG

Also known as: Coronally advanced Flap (surgery/ procedure)
Control: CAF + CTG

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 75 years of age, inclusive.
  • Subjects must have at least two teeth with buccal Miller Class I or II recession type defects, 3 mm deep and 3 mm wide on the same tooth in the contralateral quadrant of the same jaw
  • Defects should be similar in size and morphology
  • Teeth with root canals should be asymptomatic, completed at least 6 months prior
  • At least 1mm KT
  • Subjects with parafunctional habits must wear a bite guard to be included.

You may not qualify if:

  • Participation within the previous 30 days in other investigational clinical trials.
  • Class V restorations or abfractions that obliterate the CEJ.
  • Subjects whose teeth have extremely prominent root surfaces -greater than 2mm facially to the adjacent teeth measured at the level of the CEJ.
  • Systemic conditions that could influence wound healing or any other conditions that would preclude periodontal surgery.
  • Taking medications that compromise wound healing.
  • Acute infectious lesions in the areas intended for surgery.
  • Untreated moderate to severe periodontal disease.
  • Weekly or more frequent use of nicotine products within the past 6 months.
  • Females who are pregnant or lactating, or sexually active female subjects who are of childbearing potential and who are not using hormonal or barrier methods of birth control.
  • Subjects who require sedation in order to undergo surgery.
  • Molars, teeth with axial mobility or interproximal loss of attachment, or full coverage crowns or veneers do not qualify.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Seven Lakes Periodontitis

Fenton, Michigan, 99999, United States

Location

Perio Health Professionals

Houston, Texas, 77063, United States

Location

Oral Health Specialists

Tacoma, Washington, 99999, United States

Location

MeSH Terms

Conditions

Gingival Recession

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Officials

  • Michael K McGuire, DDS MSD

    PerioHealth Professionals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double-blind (Outcomes Examiner, Subject)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Split-mouth, randomized
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2019

First Posted

February 7, 2020

Study Start

September 1, 2018

Primary Completion

January 4, 2020

Study Completion

July 22, 2020

Last Updated

August 10, 2021

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations